{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:54:21Z","timestamp":1785034461800,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104154"],"award-info":[{"award-number":["82104154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973209"],"award-info":[{"award-number":["81973209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2022-BS-156"],"award-info":[{"award-number":["2022-BS-156"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic scientific research project of Liaoning Provincial Department of Education","award":["LJKQZ20222347"],"award-info":[{"award-number":["LJKQZ20222347"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s12035-025-04982-7","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:38:09Z","timestamp":1745649489000},"page":"11403-11414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-Target Inhibitor of ZJQ- 3\u2009F Against AChE\/BACE1\/GSK3\u03b2 Targets Improves the Cognitive Impairment of APP\/PS1\/Tau Triple-Transgenic Mouse Models of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"62","author":[{"given":"Nan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yue","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-tong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-chun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"4982_CR1","doi-asserted-by":"publisher","unstructured":"Fedele E (2023) Anti-Amyloid Therapies for Alzheimer\u2019s Disease and the Amyloid Cascade Hypothesis. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms241914499","DOI":"10.3390\/ijms241914499"},{"key":"4982_CR2","doi-asserted-by":"crossref","unstructured":"Alzheimer's disease facts and figures (2023) Alzheimers Dement 19:1598\u20131695","DOI":"10.1002\/alz.13016"},{"key":"4982_CR3","doi-asserted-by":"publisher","unstructured":"Ettcheto M, Cano A, Busquets O et al (2019) A metabolic perspective of late onset Alzheimer\u2019s disease. Pharmacol Res 145. https:\/\/doi.org\/10.1016\/j.phrs.2019.104255","DOI":"10.1016\/j.phrs.2019.104255"},{"key":"4982_CR4","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1021\/acsomega.9b00198","volume":"4","author":"P Paudel","year":"2019","unstructured":"Paudel P, Seong SH, Zhou Y et al (2019) Arylbenzofurans from the Root Bark of Morus alba as Triple Inhibitors of Cholinesterase, \u03b2-Site Amyloid Precursor Protein Cleaving Enzyme 1, and Glycogen Synthase Kinase-3\u03b2: Relevance to Alzheimer\u2019s Disease. ACS Omega 4:6283\u20136294","journal-title":"ACS Omega"},{"key":"4982_CR5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1089\/neu.2012.2449","volume":"29","author":"F Yu","year":"2012","unstructured":"Yu F, Zhang Y, Chuang D-M (2012) Lithium Reduces BACE1 Overexpression, Beta Amyloid Accumulation, and Spatial Learning Deficits in Mice with Traumatic Brain Injury. J Neurotrauma 29:2342\u20132351","journal-title":"J Neurotrauma"},{"key":"4982_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1172\/JCI64516","volume":"123","author":"PTT Ly","year":"2012","unstructured":"Ly PTT, Wu Y, Zou H et al (2012) Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Investig 123:224\u2013235","journal-title":"J Clin Investig"},{"key":"4982_CR7","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1038\/tp.2017.169","volume":"7","author":"EN Wilson","year":"2017","unstructured":"Wilson EN, Do Carmo S, Iulita MF et al (2017) BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology. Transl Psychiatry 7:e1190\u2013e1190","journal-title":"Transl Psychiatry"},{"key":"4982_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cbi.2012.08.010","volume":"203","author":"P Jing","year":"2013","unstructured":"Jing P, Zhang J-Y, Ouyang Q et al (2013) Lithium treatment induces proteasomal degradation of over-expressed acetylcholinesterase (AChE-S) and inhibit GSK3\u03b2. Chem Biol Interact 203:309\u2013313","journal-title":"Chem Biol Interact"},{"key":"4982_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1471-4159.2007.04975.x","volume":"104","author":"P Jing","year":"2007","unstructured":"Jing P, Jin Q, Wu J et al (2007) GSK3\u03b2 mediates the induced expression of synaptic acetylcholinesterase during apoptosis. J Neurochem 104:409\u2013419","journal-title":"J Neurochem"},{"key":"4982_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/s11064-021-03514-8","volume":"47","author":"MG Fronza","year":"2022","unstructured":"Fronza MG, Sacramento M, Alves D et al (2022) 1-(7-Chloroquinolin-4-yl)-N-(4-Methoxybenzyl)-5-Methyl-1H-1,2, 3-Triazole-4- carboxamide Reduces A\u03b2 Formation and Tau Phosphorylation in Cellular Models of Alzheimer\u2019s Disease. Neurochem Res 47:1110\u20131122","journal-title":"Neurochem Res"},{"key":"4982_CR11","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s12035-022-03159-w","volume":"60","author":"MG Fronza","year":"2022","unstructured":"Fronza MG, Sacramento M, Alves D et al (2022) QTC-4-MeOBnE Ameliorated Depressive-Like Behavior and Memory Impairment in 3xTg Mice. Mol Neurobiol 60:1733\u20131745","journal-title":"Mol Neurobiol"},{"key":"4982_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbi.2021.10.002","volume":"99","author":"MG Fronza","year":"2022","unstructured":"Fronza MG, Baldinotti R, Fetter J et al (2022) Beneficial effects of QTC-4-MeOBnE in an LPS-induced mouse model of depression and cognitive impairments: The role of blood-brain barrier permeability, NF-\u03baB signaling, and microglial activation. Brain Behav Immun 99:177\u2013191","journal-title":"Brain Behav Immun"},{"key":"4982_CR13","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/acschemneuro.9b00661","volume":"11","author":"MG Fronza","year":"2020","unstructured":"Fronza MG, Baldinotti R, Fetter J et al (2020) QTC-4-MeOBnE Rescues Scopolamine-Induced Memory Deficits in Mice by Targeting Oxidative Stress, Neuronal Plasticity, and Apoptosis. ACS Chem Neurosci 11:1259\u20131269","journal-title":"ACS Chem Neurosci"},{"key":"4982_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1021\/acschemneuro.0c00615","volume":"12","author":"MG Fronza","year":"2020","unstructured":"Fronza MG, Baldinotti R, Sacramento M et al (2020) Effect of QTC-4-MeOBnE Treatment on Memory, Neurodegeneration, and Neurogenesis in a Streptozotocin-Induced Mouse Model of Alzheimer\u2019s Disease. ACS Chem Neurosci 12:109\u2013122","journal-title":"ACS Chem Neurosci"},{"key":"4982_CR15","doi-asserted-by":"publisher","unstructured":"Fronza MG, Baldinotti R, Martins MC et al (2019) Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer\u2019s disease. Sci Rep 9. https:\/\/doi.org\/10.1038\/s41598-019-43532-9","DOI":"10.1038\/s41598-019-43532-9"},{"key":"4982_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","volume":"10","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang H (2018) Reconsideration of Anticholinesterase Therapeutic Strategies against Alzheimer\u2019s Disease. ACS Chem Neurosci 10:852\u2013862","journal-title":"ACS Chem Neurosci"},{"key":"4982_CR17","doi-asserted-by":"publisher","unstructured":"Fronza MG, Alves D, Pratic\u00f2 D et al (2023) The neurobiology and therapeutic potential of multi-targeting \u03b2-secretase, glycogen synthase kinase 3\u03b2 and acetylcholinesterase in Alzheimer\u2019s disease. Ageing Res Rev 90.\u00a0https:\/\/doi.org\/10.1016\/j.arr.2023.102033","DOI":"10.1016\/j.arr.2023.102033"},{"key":"4982_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","volume":"176","author":"P Zhang","year":"2019","unstructured":"Zhang P, Xu S, Zhu Z et al (2019) Multi-target design strategies for the improved treatment of Alzheimer\u2019s disease. Eur J Med Chem 176:228\u2013247","journal-title":"Eur J Med Chem"},{"key":"4982_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jep.2017.12.015","volume":"215","author":"AK Sahoo","year":"2018","unstructured":"Sahoo AK, Dandapat J, Dash UC et al (2018) Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer\u2019s disease. J Ethnopharmacol 215:42\u201373","journal-title":"J Ethnopharmacol"},{"key":"4982_CR20","doi-asserted-by":"publisher","unstructured":"Jiang X-w, Liu W-w, Wu Y-t et al (2020) Notopterygium incisum extract (NRE) rescues cognitive deficits in APP\/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology. J Ethnopharmacol 249. https:\/\/doi.org\/10.1016\/j.jep.2019.112433","DOI":"10.1016\/j.jep.2019.112433"},{"key":"4982_CR21","doi-asserted-by":"publisher","unstructured":"Jiang X, Lu H, Li J et al (2020) A natural BACE1 and GSK3\u03b2 dual inhibitor Notopterol effectively ameliorates the cognitive deficits in APP\/PS1 Alzheimer's mice by attenuating amyloid\u2010\u03b2 and tau pathology. Clin Transl Med. https:\/\/doi.org\/10.1002\/ctm2.50","DOI":"10.1002\/ctm2.50"},{"key":"4982_CR22","doi-asserted-by":"publisher","first-page":"32131","DOI":"10.1021\/acsomega.2c03368","volume":"7","author":"N Wang","year":"2022","unstructured":"Wang N, Liu W, Zhou L et al (2022) Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE\/BACE1\/GSK3\u03b2 for the Treatment of Alzheimer\u2019s Disease. ACS Omega 7:32131\u201332152","journal-title":"ACS Omega"},{"key":"4982_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2015.2428","volume":"37","author":"X Li","year":"2016","unstructured":"Li X, Bao X, Wang R (2016) Experimental models of Alzheimer\u2019s disease for deciphering the pathogenesis and therapeutic screening (Review). Int J Mol Med 37:271\u2013283","journal-title":"Int J Mol Med"},{"key":"4982_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","volume":"133","author":"E Drummond","year":"2016","unstructured":"Drummond E, Wisniewski T (2016) Alzheimer\u2019s disease: experimental models and reality. Acta Neuropathol 133:155\u2013175","journal-title":"Acta Neuropathol"},{"key":"4982_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD et al (2003) Triple-Transgenic Model of Alzheimer\u2019s Disease with Plaques and Tangles. Neuron 39:409\u2013421","journal-title":"Neuron"},{"key":"4982_CR26","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2174\/0929867328666210512005508","volume":"29","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kumar R, Kumar B et al (2022) Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer\u2019s Disease. Curr Med Chem 29:1757\u20131803","journal-title":"Curr Med Chem"},{"key":"4982_CR27","doi-asserted-by":"publisher","unstructured":"Zhou Y, Luo D, Shi J et al (2023) Loganin alleviated cognitive impairment in 3\u00d7Tg-AD mice through promoting mitophagy mediated by optineurin. J Ethnopharmacol 312. https:\/\/doi.org\/10.1016\/j.jep.2023.116455","DOI":"10.1016\/j.jep.2023.116455"},{"key":"4982_CR28","doi-asserted-by":"publisher","unstructured":"Conti Filho CE, Loss LB, Marcolongo-Pereira C et al (2023) Advances in Alzheimer\u2019s disease\u2019s pharmacological treatment. Front Pharmacol 14. https:\/\/doi.org\/10.3389\/fphar.2023.1101452","DOI":"10.3389\/fphar.2023.1101452"},{"key":"4982_CR29","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1007\/s12035-022-02779-6","volume":"59","author":"A Jana","year":"2022","unstructured":"Jana A, Bhattacharjee A, Das SS et al (2022) Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer\u2019s Disease. Mol Neurobiol 59:3512\u20133528","journal-title":"Mol Neurobiol"},{"key":"4982_CR30","doi-asserted-by":"publisher","first-page":"26012","DOI":"10.1021\/acsomega.3c02051","volume":"8","author":"S Fares","year":"2023","unstructured":"Fares S, El Husseiny WM, Selim KB et al (2023) Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer\u2019s Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study, ACS. Omega 8:26012\u201326034","journal-title":"Omega"},{"key":"4982_CR31","doi-asserted-by":"publisher","unstructured":"Dash UC, Swain SK, Kanhar S et al (2022) The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, \u03b2-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation. J Ethnopharmacol 282. https:\/\/doi.org\/10.1016\/j.jep.2021.114637","DOI":"10.1016\/j.jep.2021.114637"},{"key":"4982_CR32","doi-asserted-by":"publisher","unstructured":"Mu\u00f1oz-Mayorga D, Rissman RA, Morales T (2020) Reproductive status impact on tau phosphorylation induced by chronic stress. Neurobiol Stress 13. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100241","DOI":"10.1016\/j.ynstr.2020.100241"},{"key":"4982_CR33","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/cne.24577","volume":"527","author":"A Kubo","year":"2018","unstructured":"Kubo A, Misonou H, Matsuyama M et al (2018) Distribution of endogenous normal tau in the mouse brain. J Comp Neurol 527:985\u2013998","journal-title":"J Comp Neurol"},{"key":"4982_CR34","doi-asserted-by":"publisher","unstructured":"Alonso AD, Cohen LS, Corbo C et al (2018) Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability. Front Cell Neurosci 12. https:\/\/doi.org\/10.3389\/fncel.2018.00338","DOI":"10.3389\/fncel.2018.00338"},{"key":"4982_CR35","doi-asserted-by":"crossref","unstructured":"Melchior B, Mittapalli GK, Lai C et al (2019) Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease. Aging Cell 18.","DOI":"10.1111\/acel.13000"},{"key":"4982_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jnc.13018","volume":"133","author":"S Coutadeur","year":"2015","unstructured":"Coutadeur S, Benyamine H, Delalonde L et al (2015) A novel DYRK1A (Dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer\u2019s disease: effect on Tau and amyloid pathologies in vitro. J Neurochem 133:440\u2013451","journal-title":"J Neurochem"},{"key":"4982_CR37","doi-asserted-by":"publisher","unstructured":"Saura CA, Parra-Damas A (2023) Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer\u2019s disease?. Brain Commun 5. https:\/\/doi.org\/10.1093\/braincomms\/fcad142","DOI":"10.1093\/braincomms\/fcad142"},{"key":"4982_CR38","doi-asserted-by":"publisher","unstructured":"Saunders TS, Pozzolo FE, Heslegrave A et al (2023) Predictive blood biomarkers and brain changes associated with age-related cognitive decline. Brain Commun 5. https:\/\/doi.org\/10.1093\/braincomms\/fcad113","DOI":"10.1093\/braincomms\/fcad113"},{"key":"4982_CR39","doi-asserted-by":"publisher","unstructured":"Gupta A (2022) Role of Glycogen Synthase Kinase 3 in Molecular Pathology of Alzheimer\u2019s Disease. Int J Health Sci Pharma 181\u2013199. https:\/\/doi.org\/10.47992\/IJHSP.2581.6411.0093","DOI":"10.47992\/IJHSP.2581.6411.0093"},{"key":"4982_CR40","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s11064-022-03624-x","volume":"47","author":"SO El-Ganainy","year":"2022","unstructured":"El-Ganainy SO, Soliman OA, Ghazy AA et al (2022) Intranasal Oxytocin Attenuates Cognitive Impairment, \u03b2-Amyloid Burden and Tau Deposition in Female Rats with Alzheimer\u2019s Disease: Interplay of ERK1\/2\/GSK3\u03b2\/Caspase-3. Neurochem Res 47:2345\u20132356","journal-title":"Neurochem Res"},{"key":"4982_CR41","doi-asserted-by":"publisher","unstructured":"Chen Y, Chen Y, Liang Y et al (2020) Berberine mitigates cognitive decline in an Alzheimer\u2019s Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance. Biomed Pharmacother 121. https:\/\/doi.org\/10.1016\/j.biopha.2019.109670","DOI":"10.1016\/j.biopha.2019.109670"},{"key":"4982_CR42","doi-asserted-by":"publisher","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Res 1867. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","DOI":"10.1016\/j.bbamcr.2020.118664"},{"key":"4982_CR43","first-page":"220","volume":"16","author":"SD Skaper","year":"2017","unstructured":"Skaper SD, Facci L, Zusso M et al (2017) Synaptic Plasticity, Dementia and Alzheimer Disease, CNS & Neurological Disorders - Drug. Targets 16:220\u2013233","journal-title":"Targets"},{"key":"4982_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN (2023) Synapse pathology in Alzheimer\u2019s disease. Semin Cell Dev Biol 139:13\u201323","journal-title":"Semin Cell Dev Biol"},{"key":"4982_CR45","doi-asserted-by":"crossref","unstructured":"Pelucchi S, Gardoni F, Di Luca M et al (2022) Synaptic dysfunction in early phases of Alzheimer's Disease, Neuroplasticity - From Bench to Bedside pp. 417\u2013438.","DOI":"10.1016\/B978-0-12-819410-2.00022-9"},{"key":"4982_CR46","doi-asserted-by":"publisher","unstructured":"Gul S, Attaullah S, Alsugoor MH et al (2023) Folicitin abrogates scopolamine induced hyperlipidemia and oxidative stress mediated neuronal synapse and memory dysfunction in mice, Heliyon 9. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16930","DOI":"10.1016\/j.heliyon.2023.e16930"},{"key":"4982_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/ene.15043","volume":"29","author":"H Kurucu","year":"2021","unstructured":"Kurucu H, Colom-Cadena M, Davies C et al (2021) Inhibitory synapse loss and accumulation of amyloid beta in inhibitory presynaptic terminals in Alzheimer\u2019s disease. Eur J Neurol 29:1311\u20131323","journal-title":"Eur J Neurol"},{"key":"4982_CR48","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1007\/s12035-022-02784-9","volume":"59","author":"W-Y Li","year":"2022","unstructured":"Li W-Y, Gao J-Y, Lin S-Y et al (2022) Effects of Involuntary and Voluntary Exercise in Combination with Acousto-Optic Stimulation on Adult Neurogenesis in an Alzheimer\u2019s Mouse Model. Mol Neurobiol 59:3254\u20133279","journal-title":"Mol Neurobiol"},{"key":"4982_CR49","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jphysparis.2014.05.002","volume":"108","author":"A Salles","year":"2014","unstructured":"Salles A, Romano A, Freudenthal R (2014) Synaptic NF-kappa B pathway in neuronal plasticity and memory. Journal of Physiology-Paris 108:256\u2013262","journal-title":"Journal of Physiology-Paris"},{"key":"4982_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"C-H Chen","year":"2011","unstructured":"Chen C-H, Zhou W, Liu S et al (2011) Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 15:77\u201390","journal-title":"Int J Neuropsychopharmacol"},{"key":"4982_CR51","doi-asserted-by":"publisher","unstructured":"Wang C, Fan L, Khawaja RR et al (2022) Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy. Nature Commun 13. https:\/\/doi.org\/10.1038\/s41467-022-29552-6","DOI":"10.1038\/s41467-022-29552-6"}],"updated-by":[{"DOI":"10.1007\/s12035-025-05265-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000}}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:13:47Z","timestamp":1757160827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4982"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04982-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12035-025-05265-x","asserted-by":"object"}]},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the western blot band in Figure 3D (PSD95 in the cortex) and Figure 4G (GAPDH in the hippocampus).","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12035-025-05265-x","URL":"https:\/\/doi.org\/10.1007\/s12035-025-05265-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were subject to approval by the Institutional Animal Care and Use Committee at Shenyang Pharmaceutical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors agreed with the content and gave explicit consent to the formulation and publication of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}